BioSpace News Archive

Drug Development

Oncoceutics Release: ONC201 Trial Begins at NYU for Children With H3 K27M Mutant Glioma

Oncoceutics announced today that the first patient has been treated in a clinical trial of ONC201 for pediatric patients with brain tumors that contain a specific mutation called the histone H3 K27M mutation.

January 31, 2018
·
4 min read
Drug Development

FDA Allows a Phase II Clinical Trial in Stroke for NuvOx Pharma’s DDFPe

NuvOx Pharma announces that the FDA has allowed a Phase II clinical trial in 60 stroke patients to proceed to test NuvOx’s investigational drug product, dodecafluoropentane emulsion (DDFPe).

January 31, 2018
·
2 min read
Pharm Country

An Open Letter From Sinobioway Consortium to All Shareholders of Sinovac Biotech

SVA recently announced that it would hold its 2017 Annual Meeting of Shareholders in Antigua and Beijing on February 6, 2018 to, among other things, approve the re-election of SVA’s current directors.

January 31, 2018
·
9 min read
Biotech Bay

Engine Biosciences Raises $10M in Seed Financing to Accelerate Drug Discovery Using Genomics and Artificial Intelligence

The heavily oversubscribed round was co-led by Silicon Valley-based DHVC and 6 Dimensions Capital, among others.

January 31, 2018
·
6 min read
Business

Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2017 Results

Fourth quarter revenue grew 22% to $6.05 billion.

January 31, 2018
·
54 min read
Business

Lannett to Report Fiscal 2018 Second-Quarter Financial Results, Host Conference Call on Wednesday, February 7

Lannett today announced that it will report financial results for its fiscal 2018 second quarter on Wednesday, February 7, 2018, after the market closes.

January 31, 2018
·
1 min read
Drug Development

On a Roll: Sage Shows Off Early-Stage Insomnia Data

The new data supports further development of SAGE-217 in disorders associated with disruption of normal sleep.

January 31, 2018
·
8 min read
Business

The Ottawa Hospital Acquires Several Elekta Versa HD Devices for Advanced Cancer Treatment

Elekta announced today that it has signed a strategic agreement with The Ottawa Hospital in Ottawa, Ontario, Canada to deliver several Elekta Versa HD linear accelerators as well as software support and services.

January 31, 2018
·
3 min read
Deals

Golden Meditech Completes Sale of Equity Interest in China Cord Blood Corporation

Golden Meditech is pleased to announce that the sale of 65.4% of the issued share capital of China Cord Blood Corporation to Nanjing Yingpeng Huikang Medical Industry Investment Partnership has been completed.

January 31, 2018
·
1 min read
Business

Sartorius Grows Significantly Again in Sales Revenue and Earnings In 2017 – Positive Outlook For 2018

Sartorius AG, a leading international technology partner of the biopharmaceutical industry and research laboratories, grew substantially according to its preliminary figures for fiscal 2017, with sales revenue up 9.3% to 1,404.6 million euros, and increased its underlying earnings to 353.2 million euros.

January 31, 2018
·
10 min read